Education
About Us
Working with TipRanks
Follow Us
SPO Global (SPOM)
:SPOM
SPOM Stock Chart & Stats
<$0.01
>-$0.01(-16.67%)
At close: 4:00 PM EST
<$0.01
>-$0.01(-16.67%)
Day’s Range― - ―
52-Week Range― - ―
Previous CloseN/A
Volume300.00K
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)$17.22K
Total Debt (Recent Filing)$275.56K
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)-2.88
Price to Sales (P/S)0.57
P/FCF Ratio3.19
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SPOM FAQ
What was SPO Global’s price range in the past 12 months?
Currently, no data Available
What is SPO Global’s market cap?
Currently, no data Available
When is SPO Global’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were SPO Global’s earnings last quarter?
Currently, no data Available
Is SPO Global overvalued?
According to Wall Street analysts SPO Global’s price is currently Overvalued.
Does SPO Global pay dividends?
SPO Global does not currently pay dividends.
What is SPO Global’s EPS estimate?
SPO Global’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SPO Global have?
Currently, no data Available
What happened to SPO Global’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of SPO Global?
Currently, no hedge funds are holding shares in SPOM
Company Description
SPO Global
Gerpang Healthcare Group operates as a bio-pharmaceutical company that manufactures and sells genetic coating stents, HBV hepatitis B virus vaccines, monoclonal antibodies for male infertility detection, ognitive disorder functional food, and polypeptide probiotics. The company was founded in 2006 and is based in Jinan, China.
Ownership Overview
―
Insiders
―
Mutual Funds
― Other Institutional Investors
100.00% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---